Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Niloticin

Cat. No.: IBDI-431231

Niloticin, tetracyclic triterpenoid compound, is a osteoclastogenesis inhibitor. Niloticin shows anti-viral, antioxidative, and mosquitocidal activities. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways.

Size (Solid):

Product Details

Target Akt | NF-κB
Molecular Weight 456.70
SMILES C[[email protected]@]1(CC[[email protected]@]2([H])[[email protected]@H](C)C[[email protected]]([[email protected]@](O3)([H])C3(C)C)O)C([[email protected]]4([H])CC[[email protected]]12C)=CC[[email protected]](C(C)5C)([H])[[email protected]@]4(CCC5=O)C
Structure Classification Terpenoids>Triterpenes

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.